Literature DB >> 29979330

Understanding osteosarcomas.

Emily Simpson1, Heather L Brown.   

Abstract

This article reviews the cause, clinical presentation, diagnostic methods, and management of osteosarcoma, the most common primary bone tumor and third most common cancer among children and adolescents. In the 1970s, the introduction of adjuvant chemotherapy following tumor resection improved overall 10-year survival from 30% to about 50% of patients. However, since that change in management strategy, the survival rate has since plateaued, with no improvement in overall 10-year survival since the 1990s. A better understanding of this disease is the first step to help improve these numbers.

Entities:  

Mesh:

Year:  2018        PMID: 29979330     DOI: 10.1097/01.JAA.0000541477.24116.8d

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  60 in total

1.  Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2.

Authors:  Shenglong Li; Yi Pei; Wei Wang; Fei Liu; Ke Zheng; Xiaojing Zhang
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

2.  LncRNA UCA1 accelerates osteosarcoma progression via miR-145 and Wnt/β-catenin pathway.

Authors:  Jian Guan; Juliang He; Shian Liao; Zhenjie Wu; Xiang Lin; Bin Liu; Xiong Qin; Jiachang Tan; Chuangming Huang; Zhenchao Yuan; Hao Mo
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 3.  Therapeutic Potential of Triptolide in Treating Bone-Related Disorders.

Authors:  Wu Gang; Hu Hao; Huang Yong; Feng Ruibing; Li Chaowen; Huang Yizheng; Li Chao; Zhang Haitao
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

4.  Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion.

Authors:  Yi-Xin Du; Lin-Xin Guo; Han-Song Pan; Yi-Min Liang; Xiang Li
Journal:  Hum Cell       Date:  2019-10-30       Impact factor: 4.174

Review 5.  Update on Osteosarcoma.

Authors:  Rebekah Belayneh; Mitchell S Fourman; Sumail Bhogal; Kurt R Weiss
Journal:  Curr Oncol Rep       Date:  2021-04-21       Impact factor: 5.075

6.  Do Not Miss the Tumor: A Novel Presentation of Osteosarcoma.

Authors:  Michael DePalma; Sachin Gupta; Jie Nguyen; Divya Talwar; Alexandre Arkader; Lawrence Wells
Journal:  Case Rep Pediatr       Date:  2021-05-13

Review 7.  Osteosarcoma: a review of current and future therapeutic approaches.

Authors:  Xin Zhao; Qirui Wu; Xiuqing Gong; Jinfeng Liu; Yujie Ma
Journal:  Biomed Eng Online       Date:  2021-03-02       Impact factor: 2.819

8.  12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.

Authors:  Emel Rothzerg; Jiake Xu; David Wood; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

9.  NUSAP1 Accelerates Osteosarcoma Cell Proliferation and Cell Cycle Progression via Upregulating CDC20 and Cyclin A2.

Authors:  Haoran Wang; Zixiang Liu; Peng Wu; Hanqing Wang; Weiwei Ren
Journal:  Onco Targets Ther       Date:  2021-05-25       Impact factor: 4.147

Review 10.  The Emerging Role of Circ-SHPRH in Cancer.

Authors:  Xinyue Ju; Yan Tang; Rongfeng Qu; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2021-07-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.